Investing.com - Sanofi ADR (NASDAQ: SNY) reported third quarter EPS of $2.55, $1.17 better than the analyst estimate of $1.38. Revenue for the quarter came in at $11.96B versus the consensus estimate of $13.2B.
Sanofi ADR's stock price closed at $53.33. It is up 1.62% in the last 3 months and up 23.88% in the last 12 months.
Sanofi ADR saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Sanofi ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Sanofi ADR's Financial Health score is "great performance".
Check out Sanofi ADR's recent earnings performance, and Sanofi ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar